2,3-dinor-thromboxane b2 has been researched along with Abnormality, Heart in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adatia, I; Barrow, SE; Haworth, SG; Miall-Allen, VM; Ritter, JM; Stratton, PD | 1 |
| Adatia, I; Barrow, SE; Haworth, SG; Ritter, JM; Stratton, P | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and Abnormality, Heart
| Article | Year |
|---|---|
Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aging; Cardiac Surgical Procedures; Child; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Male; Postoperative Period; Pulmonary Heart Disease; Reference Values; Thromboxane A2; Thromboxane B2 | 1993 |
Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Infant; Male; Thromboxane A2; Thromboxane B2; Ventricular Outflow Obstruction | 1993 |